KRRO Selects KRRO-111 for AATD Treatment, Demonstrates >90% SERPINA1 Editing, ~90% Repaired AAT Protein in Preclinical Studies
Korro Bio, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $13.41
+47% in 7d after detection
Post-detection moves
1h
—
1d
+9.4%
3d
+27%
7d
+47%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS